MedPath

Respiratory Muscle Strength in Patients With Obesity Hypoventilation Syndrome (OHS) or With a Precursor of the Disease

Recruiting
Conditions
Obesity Hypoventilation Syndrome
Registration Number
NCT03854058
Lead Sponsor
Wissenschaftliches Institut Bethanien e.V
Brief Summary

Using an extensive set of both volitional and non-volitional tests of respiratory muscle function and strength it is the aim of this study to

* identify potential determinants for the development of obesity hypoventilation

* to identify predictors for the presence of a sleep-related hypoventilation requiring treatment in obese patients

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • patients with BMI > 30 and obesity-associated hypoventilation stages I - IV
  • patients with BMI > 30 and elevated OHS-risk (= obstructive sleep apnea without hypercapnia)
  • age:18-80 years
  • capacity to consent
Exclusion Criteria
  • any other disease, that causes ventilatory insufficiency
  • pacemaker, defibrillators or device for deep brain or vagus nerve stimulation
  • esophagitis, Barrett-esophagus, esophageal cancer
  • acute gastritis and ulcera ventriculi
  • epilepsy
  • any medical, psychological or other condition impairing the patient's ability to provide informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
transdiaphragmatic pressure (non-volitional)1 day

difference between intraesophageal and intragastral pressure after posterior magnetic stimulation of the phrenic nerves

diaphragmal ultrasound - thickness (non-volitional)1 day

thickness of the diaphragm

P0.1 (volitional)1 day

mouth occlusion pressure (kPa)

peripheral nervous system (non-volitional)1 day

electroneurography after posterior magnetic stimulation of the phrenic nerves

Carbon dioxide rebreathing test1 day

minute volumen (L/min)

diaphragmal ultrasound - excursion (non-volitional)1 day

excursion of the diaphragm

PImax (volitional)1 day

maximal inspiratory mouth pressure (kPa)

Secondary Outcome Measures
NameTimeMethod
Comparison of PImax and transdiaphragmatic pressure1 day

Correlation between PImax and transdiaphragmatic pressure

Trial Locations

Locations (1)

Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V.

🇩🇪

Solingen, Nordrhein-Westfalen, Germany

Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V.
🇩🇪Solingen, Nordrhein-Westfalen, Germany
Anja Pietzke-Calcagnile
Contact
0212636663
institut@klinik-bethanien.de
Marcel Treml
Contact
0212636661
institut@klinik-bethanien.de

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.